Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.210
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $91.16 million as of January 2, 2026. Its market cap has decreased by -62.16% in one year.
Market Cap
91.16M
Enterprise Value
71.17M
1-Year Change
-62.16%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $91.16M, a decrease of -93.16%. That is a compound annual growth rate of -40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.79B |
| Johnson & Johnson | 499.01B |
| AbbVie | 404.59B |
| UnitedHealth Group | 300.92B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 262.95B |
| Novo Nordisk | 227.80B |